Aspira Women's Health Inc. (AWH) DCF Valuation

Aspira Women's Health Inc. (AWH) DCF Valuation
  • Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • Aucune Expertise N'Est Requise; Facile À Suivre

Aspira Women's Health Inc. (AWH) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Optimize your time and improve precision with our (AWH) DCF Calculator! Utilizing actual data from Aspira Women's Health Inc. and customizable assumptions, this tool empowers you to forecast, analyze, and value (AWH) like a seasoned investor.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue 4.5 4.7 6.8 8.2 9.2 11.0 13.2 15.9 19.1 23.0
Revenue Growth, % 0 2.49 46.46 20.14 11.85 20.24 20.24 20.24 20.24 20.24
EBITDA -14.9 -17.7 -32.3 -30.9 -16.5 -11.0 -13.2 -15.9 -19.1 -23.0
EBITDA, % -329.33 -380.91 -474.06 -377.25 -180.15 -100 -100 -100 -100 -100
Depreciation .3 .3 .3 .3 .2 .5 .6 .8 .9 1.1
Depreciation, % 7.34 6.26 4.98 3.29 2.17 4.81 4.81 4.81 4.81 4.81
EBIT -15.3 -18.0 -32.6 -31.1 -16.7 -11.0 -13.2 -15.9 -19.1 -23.0
EBIT, % -336.67 -387.16 -479.04 -380.54 -182.32 -100 -100 -100 -100 -100
Total Cash 11.7 16.6 37.2 13.3 2.6 9.4 11.3 13.6 16.4 19.7
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .9 .9 1.0 1.2 1.5
Account Receivables, % 20.36 18.6 15.08 15.21 15.94
Inventories .0 .0 .2 .3 .2 .2 .3 .3 .4 .5
Inventories, % 0.5509 0.64502 2.55 3.86 2.48 2.02 2.02 2.02 2.02 2.02
Accounts Payable 1.2 1.1 1.5 .9 1.3 2.1 2.5 3.0 3.7 4.4
Accounts Payable, % 25.52 23.72 22.03 10.76 13.78 19.16 19.16 19.16 19.16 19.16
Capital Expenditure -.1 -.5 -.2 -.2 .0 -.4 -.5 -.6 -.7 -.9
Capital Expenditure, % -2.93 -10.54 -2.7 -2.83 -0.26218 -3.85 -3.85 -3.85 -3.85 -3.85
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -14.9 -17.7 -32.7 -24.7 -16.7 -10.5 -12.6 -15.1 -18.2 -21.9
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -14.5 -17.9 -32.4 -25.7 -16.3 -9.9 -12.5 -15.0 -18.0 -21.6
WACC, % 9.21 9.22 9.24 8.97 9.24 9.18 9.18 9.18 9.18 9.18
PV UFCF
SUM PV UFCF -57.7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -22
Terminal Value -308
Present Terminal Value -198
Enterprise Value -256
Net Debt 0
Equity Value -256
Diluted Shares Outstanding, MM 9
Equity Value Per Share -27.75

What You Will Get

  • Editable Forecast Inputs: Effortlessly modify assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Aspira Women's Health Inc. (AWH) financial data pre-filled to kickstart your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A sleek Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Aspira Women's Health Inc. (AWH).
  • WACC Calculator: Includes a pre-built Weighted Average Cost of Capital sheet with customizable inputs specific to AWH.
  • Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit AWH's financial projections.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to Aspira Women's Health Inc. (AWH).
  • Interactive Dashboard and Charts: Visual representations summarize key valuation metrics for streamlined analysis of AWH.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based AWH DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically recalculates Aspira Women's Health Inc.'s intrinsic value.
  4. Test Scenarios: Experiment with different assumptions to assess potential valuation impacts.
  5. Analyze and Decide: Leverage the results to inform your investment or financial decisions.

Why Choose Aspira Women's Health Inc. (AWH) Calculator?

  • Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses tailored for women's health.
  • Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
  • Detailed Insights: Automatically computes Aspira’s intrinsic value and Net Present Value.
  • Preloaded Data: Historical and projected data provide reliable starting points for analysis.
  • Professional Quality: Perfect for healthcare analysts, investors, and business consultants focused on women's health.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Aspira Women's Health Inc. (AWH) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to Aspira Women's Health Inc. (AWH).
  • Consultants: Deliver professional valuation insights related to Aspira Women's Health Inc. (AWH) to clients quickly and accurately.
  • Business Owners: Understand how companies like Aspira Women's Health Inc. (AWH) are valued to inform your own business strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios focused on Aspira Women's Health Inc. (AWH).

What the Template Contains

  • Pre-Filled Data: Includes Aspira Women's Health Inc.'s (AWH) historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Aspira Women's Health Inc.'s (AWH) profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.